Protective Efficacy of CAP18 sub(106-138)-Immunoglobulin G in Sepsis

Naturally present antibacterial proteins play an important role in innate host defense. A synthetic peptide mimicking the C-terminal lipopolysaccharide (LPS)-binding domain of rabbit cathelicidin CAP18 was coupled to immunoglobulin (Ig) G to create CAP18 sub(106-138)-IgG, a construct that, in concentrations equimolar to those of peptide alone, binds and neutralizes LPS and kills multiple gram-negative bacterial strains. The protective efficacy of CAP18 sub(106-138)-IgG was evaluated in a model of cecal ligation and puncture in mice. A single intravenous administration of 20 mg/kg CAP18 sub(106-138-IgG)-protected against mortality, compared with sham-coupled IgG (P < .03). There was no protection offered by administration of equimolar peptide alone (P = .96). There was a trend toward protection in C3H/HeJ mice that are minimally sensitive to LPS (P = .06), suggesting that direct detoxification of LPS was not the only mechanism of protection. Chemical or genetic coupling of antimicrobial peptides to IgG may be a means of using these peptides to treat infections.